| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/ERN.09.121 |
| P698 | PubMed publication ID | 19951131 |
| P2093 | author name string | Helen Rodgers | |
| Lisa Shaw | |||
| P2860 | cites work | Botulism | Q21994439 |
| Prevalence of spasticity post stroke. | Q34145923 | ||
| Spasticity after stroke: its occurrence and association with motor impairments and activity limitations | Q34284926 | ||
| Botulinum treatment of spasticity: why is it so difficult to show a functional benefit? | Q34448873 | ||
| Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature | Q34645518 | ||
| Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial | Q35458739 | ||
| Clostridial neurotoxins | Q35576550 | ||
| Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins | Q35831352 | ||
| Spasticity: clinical perceptions, neurological realities and meaningful measurement | Q36084060 | ||
| Biomechanical approaches applied to the lower and upper limb for the measurement of spasticity: a systematic review of the literature. | Q36084068 | ||
| Neurophysiological methods for the assessment of spasticity: the Hoffmann reflex, the tendon reflex, and the stretch reflex | Q36084072 | ||
| Theoretical and methodological considerations in the measurement of spasticity | Q36084077 | ||
| Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. | Q36185790 | ||
| Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. | Q36227094 | ||
| Management of spasticity. | Q36316593 | ||
| Pharmacology of botulinum toxin: differences between type A preparations | Q36370612 | ||
| Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc | Q36370617 | ||
| Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting | Q36511574 | ||
| Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques | Q36511618 | ||
| The structure and mode of action of different botulinum toxins | Q36656462 | ||
| Safety and efficacy of botulinum toxin type A following long-term use. | Q36656478 | ||
| From poison to remedy: the chequered history of botulinum toxin | Q36801432 | ||
| Pharmacology of therapeutic botulinum toxin preparations | Q37011510 | ||
| Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. | Q37032412 | ||
| Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity | Q37103149 | ||
| Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review. | Q37395495 | ||
| Dysport: pharmacological properties and factors that influence toxin action | Q37426847 | ||
| Effect of treatment with botulinum toxin on spasticity | Q39198056 | ||
| Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial. | Q39333120 | ||
| Do nerve terminal sprouts contribute to functional recovery from botulinum neurotoxin A? | Q46133769 | ||
| Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke | Q47228741 | ||
| Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial | Q47642393 | ||
| Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes | Q49162611 | ||
| P433 | issue | 12 | |
| P921 | main subject | spasticity | Q117060 |
| botulinum toxin type A | Q4095199 | ||
| P304 | page(s) | 1713-1725 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Botulinum toxin type A for upper limb spasticity after stroke | |
| P478 | volume | 9 |
| Q47171933 | A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity. |
| Q38644683 | Adverse Clinical Effects of Botulinum Toxin Intramuscular Injections for Spasticity |
| Q36395728 | Clinical uses of botulinum neurotoxins: current indications, limitations and future developments |
| Q38986438 | Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review |
| Q37806619 | Use of botulinum toxin in the neurology clinic |
Search more.